BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35338595)

  • 1. Pitfalls of X-chromosome inactivation testing in females with Fabry disease.
    Řeboun M; Sikora J; Magner M; Wiederlechnerová H; Černá A; Poupětová H; Štorkánova G; Mušálková D; Dostálová G; Goláň L; Linhart A; Dvořáková L
    Am J Med Genet A; 2022 Jul; 188(7):1979-1989. PubMed ID: 35338595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female Fabry disease patients and X-chromosome inactivation.
    Juchniewicz P; Kloska A; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Węgrzyn G; Moskot M; Gabig-Cimińska M; Piotrowska E
    Gene; 2018 Jan; 641():259-264. PubMed ID: 29079200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation impact on Fabry disease.
    Di Risi T; Vinciguerra R; Cuomo M; Della Monica R; Riccio E; Cocozza S; Imbriaco M; Duro G; Pisani A; Chiariotti L
    Clin Epigenetics; 2021 Feb; 13(1):24. PubMed ID: 33531072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-chromosomal inactivation patterns in women with Fabry disease.
    Wagenhäuser L; Rickert V; Sommer C; Wanner C; Nordbeck P; Rost S; Üçeyler N
    Mol Genet Genomic Med; 2022 Sep; 10(9):e2029. PubMed ID: 35971858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-chromosome inactivation in female patients with Fabry disease.
    Echevarria L; Benistan K; Toussaint A; Dubourg O; Hagege AA; Eladari D; Jabbour F; Beldjord C; De Mazancourt P; Germain DP
    Clin Genet; 2016 Jan; 89(1):44-54. PubMed ID: 25974833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay.
    Rossanti R; Nozu K; Fukunaga A; Nagano C; Horinouchi T; Yamamura T; Sakakibara N; Minamikawa S; Ishiko S; Aoto Y; Okada E; Ninchoji T; Kato N; Maruyama S; Kono K; Nishi S; Iijima K; Fujii H
    Clin Exp Nephrol; 2021 Nov; 25(11):1224-1230. PubMed ID: 34128148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing.
    Peng H; Xu X; Zhang L; Zhang X; Peng H; Zheng Y; Luo S; Guo H; Xia K; Li J; Yao H; Hu Z
    Gene; 2016 Jan; 575(2 Pt 1):363-7. PubMed ID: 26456105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-inactivation in Fabry disease.
    Elstein D; Schachamorov E; Beeri R; Altarescu G
    Gene; 2012 Sep; 505(2):266-8. PubMed ID: 22710134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.
    Izhar R; Borriello M; La Russa A; Di Paola R; De A; Capasso G; Ingrosso D; Perna AF; Simeoni M
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GLA T194A variant causes Fabry disease.
    Pestana MN; Gomes da Silva F; Durães J; Silva G
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33649041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
    Duro G; Zizzo C; Cammarata G; Burlina A; Burlina A; Polo G; Scalia S; Oliveri R; Sciarrino S; Francofonte D; Alessandro R; Pisani A; Palladino G; Napoletano R; Tenuta M; Masarone D; Limongelli G; Riccio E; Frustaci A; Chimenti C; Ferri C; Pieruzzi F; Pieroni M; Spada M; Castana C; Caserta M; Monte I; Rodolico MS; Feriozzi S; Battaglia Y; Amico L; Losi MA; Autore C; Lombardi M; Zoccali C; Testa A; Postorino M; Mignani R; Zachara E; Giordano A; Colomba P
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.
    Ferri L; Guido C; la Marca G; Malvagia S; Cavicchi C; Fiumara A; Barone R; Parini R; Antuzzi D; Feliciani C; Zampetti A; Manna R; Giglio S; Della Valle CM; Wu X; Valenzano KJ; Benjamin R; Donati MA; Guerrini R; Genuardi M; Morrone A
    Clin Genet; 2012 Mar; 81(3):224-33. PubMed ID: 21517827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance.
    Smid BE; Hollak CE; Poorthuis BJ; van den Bergh Weerman MA; Florquin S; Kok WE; Lekanne Deprez RH; Timmermans J; Linthorst GE
    Clin Genet; 2015 Aug; 88(2):161-6. PubMed ID: 25040344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report.
    Rodríguez Doyágüez P; Furlano M; Ars Criach E; Arce Y; Guirado L; Torra Balcells R
    Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():91-95. PubMed ID: 38278716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis.
    Viggiano E; Politano L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
    Rosa Neto NS; Bento JCB; Pereira RMR
    Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.
    Dobrovolny R; Dvorakova L; Ledvinova J; Magage S; Bultas J; Lubanda JC; Elleder M; Karetova D; Pavlikova M; Hrebicek M
    J Mol Med (Berl); 2005 Aug; 83(8):647-54. PubMed ID: 15806320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
    Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
    Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation identification of Fabry disease in families with other lysosomal storage disorders.
    Zampetti A; Fania L; Antuzzi D; Giurdanella F; Gnarra M; Bertola F; Lualdi S; Filocamo M; Morrone A; Feliciani C
    Clin Genet; 2013 Sep; 84(3):281-5. PubMed ID: 23210910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.